Norman S Ober, MD in Southborough, MA - General Practice

Norman S Ober, MD is a General Practice physician based in Southborough, Massachusetts. Norman S Ober is licensed to practice in Massachusetts (license number 58441) and his current practice location is 15 Ledge Hill Rd, Southborough, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (508) 485-4052.

NPI number for Norman S Ober is 1881731123 and his current mailing address is 15 Ledge Hill Rd, Southborough, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1881731123.

Contact Information

	Norman S Ober, MD
	15 Ledge Hill Rd, Southborough, MA 01772-1116
	(508) 485-4052
	Not Available

Physician's Profile

Full Name	Norman S Ober
Gender	Male
Speciality	General Practice
Location	15 Ledge Hill Rd, Southborough, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1881731123
Provider Enumeration Date: 01/30/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Norman S Ober such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881731123	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	58441 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Norman S Ober is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Norman S Ober, MD 15 Ledge Hill Rd, Southborough, MA 01772-1116 Ph: (508) 485-4052	Norman S Ober, MD 15 Ledge Hill Rd, Southborough, MA 01772-1116 Ph: (508) 485-4052

News Archive

Preventing, detecting, and treating coronary artery disease

A woman who has heart disease is 50% more likely to die from it than a man who has it.

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

Childhood burns victims experience higher rates of depression, suicidal thoughts

Adults who have been hospitalized for a burn as a child experience higher than usual rates of depression and suicidal thoughts, according to new research at the University of Adelaide.

WHO survey: COVID-19 halted mental health services in 93% of countries

The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey.

Norman S Ober, MD - General Practice in Southborough, MA